Resonance Specialties Limited Board Meeting Scheduled for May 14, 2026 to Consider Q4FY26 Results

1 min read     Updated on 30 Apr 2026, 06:43 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Resonance Specialties Limited has scheduled a Board Meeting on May 14, 2026, to consider audited financial results for Q4FY26 and FY26, and to recommend dividend for the financial year. The trading window for insiders remains closed from March 31, 2026, until 48 hours after results declaration.

powered bylight_fuzz_icon
39100411

*this image is generated using AI for illustrative purposes only.

Resonance Specialties Limited has announced that its Board of Directors will meet on Thursday, May 14, 2026, pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting has been convened to consider and approve the audited financial results for the fourth quarter and financial year ended March 31, 2026, and to recommend a dividend for the said financial year.

Key Agenda Items

The Board meeting will primarily focus on two significant matters:

  • Consideration and approval of audited financial results for Q4FY26 and FY26
  • Recommendation of dividend for the financial year ended March 31, 2026

Trading Window Closure

In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has informed that the trading window for dealing in the securities of the company by insiders remains closed. The closure period commenced from the close of business hours on March 31, 2026, and will continue until 48 hours after the declaration of the company's audited financial results for the fourth quarter and financial year ended March 31, 2026.

Company Details

Particulars Details
Company Name Resonance Specialties Limited
BSE Scrip Code 524218
CIN L25209MH1989PLCO51993
Registered Office Plot No. 54-D, Kandivli Industrial Estate, Kandivali (W), Mumbai - 400067, India

The intimation was submitted through online filing on April 30, 2026, and was digitally signed by Vaibhavi Shah, Company Secretary of Resonance Specialties Limited.

Historical Stock Returns for Resonance Specialties

1 Day5 Days1 Month6 Months1 Year5 Years
+1.57%+10.09%+18.38%+21.13%+39.33%-18.50%

What factors could influence the dividend amount that Resonance Specialties' board will recommend for FY 2025-26?

How might the Q4 and FY 2026 financial results impact Resonance Specialties' stock price when trading resumes?

What strategic initiatives or capital allocation plans might the company announce alongside their financial results?

like18
dislike

Resonance Specialties Limited Files Q4FY26 Compliance Certificate Under SEBI Regulations

1 min read     Updated on 06 Apr 2026, 06:45 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Resonance Specialties Limited submitted its Q4FY26 compliance certificate under SEBI Regulation 74(5) to BSE Limited on April 6, 2026. The filing included confirmation from registrar Adroit Corporate Services that all securities received for dematerialization during the quarter ended March 31, 2026 were properly processed, with certificates mutilated and depository names substituted in member registers within prescribed timelines.

powered bylight_fuzz_icon
37026942

*this image is generated using AI for illustrative purposes only.

Resonance Specialties Limited has filed its mandatory quarterly compliance certificate with BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026.

Regulatory Filing Details

The company submitted the certificate on April 6, 2026, in compliance with Regulation 74(5) of SEBI regulations. The filing was made through online submission to BSE Limited, where Resonance Specialties Limited trades under scrip code 524218.

Filing Parameter: Details
Filing Date: April 6, 2026
Quarter Covered: Q4FY26 (ended March 31, 2026)
Exchange: BSE Limited
Scrip Code: 524218
Regulation: SEBI Regulation 74(5)

Registrar Confirmation Certificate

The submission included a confirmation certificate from Adroit Corporate Services Private Limited, the company's registrar and share transfer agent. The certificate, dated April 1, 2026, provides comprehensive confirmation of compliance with dematerialization processes during the quarter.

Adroit Corporate Services confirmed that all securities received from depository participants for dematerialization during Q4FY26 were properly processed and confirmed to the depositories. The registrar verified that these securities have been listed on stock exchanges where the company's previously issued securities are already listed.

Dematerialization Process Compliance

The certificate confirms adherence to prescribed procedures for handling physical securities:

  • Securities received for dematerialization were confirmed (accepted/rejected) to depositories
  • Security certificates were mutilated and cancelled after due verification by depository participants
  • Depository names were substituted in the register of members as registered owners
  • All processes were completed within the mandated 15-day timeline

Corporate Governance Framework

The filing was signed by Vaibhavi Shah, Company Secretary & Compliance Officer (ACS: 72229), demonstrating the company's commitment to maintaining proper corporate governance standards. The digital signature was applied on April 6, 2026, ensuring authenticity and compliance with electronic filing requirements.

This quarterly compliance certificate represents part of Resonance Specialties Limited's ongoing regulatory obligations, ensuring transparency in share transfer and dematerialization processes for investor protection and market integrity.

Historical Stock Returns for Resonance Specialties

1 Day5 Days1 Month6 Months1 Year5 Years
+1.57%+10.09%+18.38%+21.13%+39.33%-18.50%

Will Resonance Specialties Limited's consistent regulatory compliance improve its ESG ratings and attract institutional investors in FY27?

How might the company's dematerialization efficiency impact its eligibility for inclusion in major stock indices or ETFs?

Could the smooth Q4FY26 compliance process indicate preparation for any upcoming corporate actions like bonus issues or stock splits?

like17
dislike

More News on Resonance Specialties

1 Year Returns:+39.33%